By Hugo Francisco de Souza Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial ...
Operational context includes a significant reduction in personnel and infrastructure costs following a 2025 restructuring to ...
The first engineered cell therapy has come to the fight against solid tumors. Fox Chase Cancer Center has begun using Tecelra ...
A MEDICINE for hypertension has been delisted by the Food and Drug Administration (FDA) from the updated list of Value-Added ...
Adults with differentiated thyroid cancer who are using a GLP-1 for the treatment of diabetes or obesity do not have increased risk for cancer recurrence or progression vs. those not using a GLP-1, ...
Deep in our cells, a wide range of processes are occurring constantly. These cellular processes rely on enzymes to act as catalysts and set off a series of molecular interactions. There are still many ...
Researchers announced in February 2026 that small fragments of plastic were found in nine out of 10 prostate tumor samples, adding new urgency to a growing body of evidence connecting everyday plastic ...
Results in a population of 278 patients affirm statistically significant mortality reductionsBenefits observed across severity groups and in ...
The very popular wonder drug for the treatment of obesity and diabetes, T2, GLP-1 receptor agonist (Ozempic, Wegovy, Monjaro, etc.), with sustained use, is associated with a higher risk for ...
Studies have demonstrated a critical role of the cytokines thymic stromal lymphopoietin (TSLP), IL-33, and IL-25, produced by epithelial and other cells at mucosal surfaces in response to a wide range ...
JS207, Junshi Biosciences’ independently developed recombinant humanized anti-PD-1/VEGF bispecific antibody, has demonstrated promising anti-tumor activity and a manageable safety profile in both ...
And one simulation shows just what impact it can have on you if you become dependent or addicted to weed and smoke it every day from your youth. Similarly, one former addict opened up about what ...